BOSTON, June 10, 2022 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in Goldman Sachs’ 43rd Annual Global Healthcare Conference, on June 15, 2022, at 10:40 a.m. PT.
Further details, a webcast link, and a replay of the presentation, if available, will be posted on the company’s investor relations website at https://investors.ginkgobioworks.com/events.
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company’s platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit
Ginkgo Bioworks Contacts:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-goldman-sachs-43rd-annual-global-healthcare-conference-301566039.html
SOURCE Ginkgo Bioworks
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.